ரொபெர்டோ லத்தினி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ரொபெர்டோ லத்தினி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ரொபெர்டோ லத்தினி Today - Breaking & Trending Today

Diesel shortages paralyze Venezuelan farms, prompting sanctions debate

Diesel shortages paralyze Venezuelan farms, prompting sanctions debate
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

United States , Distrito Federal , White House , District Of Columbia , Juan Gonzalez , Santiago De Cuba , Roberto Latini , Marcos Mendoza Invernadero Tintorero , Efrain Otero , Luc Cohen , Juan Guaido , Hugo Chavez , Edison Arciniega , Nicolas Maduro , Matt Spetalnick , Joe Biden , Agustin Zenere , Luis Colmenares , Estanislao Wawrzyniak , Keren Torres , Thomson Reuters Trust Principles , United Nations , Treasury Department , National Security Council , Us State Department , South American ,

Another Weight-Loss Trial Win for Weekly GLP-1 Drug

email article
When paired with lifestyle management, once-weekly semaglutide (Ozempic) yielded significant weight loss for overweight adults with type 2 diabetes, the manufacturer-sponsored Semaglutide Treatment Effect in People with Obesity (STEP) 2 study found.
In the superiority phase III trial of over 1,200 adults with a body mass index (BMI) of at least 27, those on 2.4 mg of weekly subcutaneous semaglutide lost an average of 9.6% of baseline body weight after 68 weeks of treatment versus 3.4% for those on placebo and lifestyle intervention alone (treatment difference -6.2 percentage points, 95% CI -7.3 to -5.2,
P 0.0001), reported Ildiko Lingvay, MD, of the University of Texas Southwestern Medical Center in Dallas, and colleagues. ....

New York , United States , South Africa , Roberto Latini , Pliraglutide Saxenda , Lidia Staszewsky , Mario Negri Institute Of Pharmacological Research , Novo Nordisk , Semaglutide Treatment Effect , Mario Negri Institute , Pharmacological Research , North America , South America , Middle East , New York City , Weight Decreased , Diabetes Mellitus Type 2 , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ரொபெர்டோ லத்தினி , மரியோ நெக்ரி நிறுவனம் ஆஃப் மருந்தியல் ஆராய்ச்சி , மரியோ நெக்ரி நிறுவனம் , மருந்தியல் ஆராய்ச்சி , வடக்கு அமெரிக்கா , தெற்கு அமெரிக்கா , நடுத்தர கிழக்கு ,